Dr. Elisabeth McClymont is a CTN/CANFAR Postdoctoral Fellow at l’Université de Montréal, under the supervision of Drs. Soren Gantt and Isabelle Boucoiran. Her postdoctoral research focuses on CMV transmission among women living with and without HIV and their children. She aims to elucidate the dose dependence between CMV viral load of exposure and risk of CMV transmission, and to describe CMV transmitted/founder viruses to determine if they display genotypic features that distinguish them from non-transmitted viruses. Findings from this work will ensure that the parameters of a successful CMV vaccine are described not only for the general population, but also for women living with HIV, who are particularly vulnerable to CMV infection.
Prior to her postdoctoral fellowship, Dr. McClymont has built a strong portfolio researching HPV infection and HPV vaccination in women living with HIV. She completed a PhD in Reproductive and Developmental Sciences supervised by Dr. Deborah Money at the University of British Columbia. She has received a number of awards, including ASTDA IUSTI Emerging Investigator, IDSOG Young Investigator of the Year, and Dr. Bernard Duval Award for Vaccination.